Skip to main content

Media

Latest News

April 9, 2021

Congressman Ro Khanna of California was the first House Democrat to speak out Friday against President Joe Biden's request for a $715 billion Pentagon budget for Fiscal Year 2022, an increase from the current $704 billion level approved under former President Donald Trump.


April 6, 2021

Washington, DC – Today, Res. Ro Khanna (CA-17), Debbie Dingell (MI-12), and Mark Pocan (WI-02) led 76 of their colleagues in calling for the Biden Administration to publicly increase pressure on Saudi Arabia to lift the blockade on Yemen immediately, unilaterally, and comprehensively.


March 31, 2021
Newsletter Archive

Good afternoon. I would like to provide a few updates about recent developments in Congress and share some important information.

Lowering Prescription Drug Prices


March 26, 2021

Congressional Democrats are introducing legislation to transfer $1bn in funding from a controversial new intercontinental ballistic missile to the development of a universal Covid vaccine.


March 25, 2021

Washington, DC – Chairman Rep. Ro Khanna (CA-17) of the Subcommittee on Environment announced today that Rep. Rashida Tlaib (MI-13) will serve as Vice Chair.


March 23, 2021

Washington, DC - Sen. Bernie Sanders (I-VT) and Reps. Ro Khanna, (D-CA), Lloyd Doggett (D-TX), Peter Welch (D-VT), and Cori Bush (D-MO), along with more than two dozen colleagues, on Tuesday introduced sweeping legislation to drastically reduce the cost of prescription drugs in the United States.


March 22, 2021

US Representative Ro Khanna is consistent. The California Democrat was an outspoken critic of former president Donald Trump's unauthorized use of military force in the Middle East, and he immediately objected when President Joe Biden ordered air strikes targeting Iranian-backed militias in Syria on February 25.


March 22, 2021

Sen. Bernie Sanders, an independent from Vermont and the chairman of the Senate Budget Committee, is set to unveil a trio of bills designed to lower the cost of prescription drugs and give American consumers access to the competitive global drug market.